TFA
VRTX icon

Teamwork Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Teamwork Financial Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-519
Closed -$231K – 218
2025
Q2 		$231K Sell
519
-204
-28% -$94K 0.03% 173
2025
Q1 		$351K Sell
723
-1,994
-73% -$929K 0.05% 135
2024
Q4 		$1.09M Sell
2,717
-7,378
-73% -$3.42M 0.14% 85
2024
Q3 		$4.69M Buy
10,095
+9,497
+1,588% +$4.56M 0.65% 34
2024
Q2 		$280K Sell
598
-20,654
-97% -$8.96M 0.04% 116
2024
Q1 		$8.88M Buy
21,252
+19,173
+922% +$8.11M 1.37% 28
2023
Q4 		$846K Sell
2,079
-14,429
-87% -$5.33M 0.15% 74
2023
Q3 		$5.74M Buy
16,508
+1,445
+10% +$505K 0.94% 27
2023
Q2 		$5.3M Buy
+15,063
New +$5.08M 0.86% 28

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Teamwork Financial Advisors's VRTX Position: Q3 2025 in Review

Teamwork Financial Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 519 shares — an estimated $231K sold.

Teamwork Financial Advisors first reported a position in VRTX in Q2 2023 and held it in 9 quarters. The position peaked at $8.88M in Q1 2024. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Teamwork Financial Advisors reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Teamwork Financial Advisors sold 519 Vertex Pharmaceuticals shares in Q3 2025, an estimated $231K.
  • Teamwork Financial Advisors first reported a position in Vertex Pharmaceuticals in Q2 2023 and held it in 9 quarters.
  • Teamwork Financial Advisors's Vertex Pharmaceuticals position peaked at $8.88M in Q1 2024.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Teamwork Financial Advisors's 13F filing for Q3 2025, filed 8 Oct 2025.